Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (3696083 Ergebnisse gefunden) Es werden maximal 1000 E.
| Datum | Thema | |
|---|---|---|
| 14:01 | Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026 | |
| SAN CARLOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will host a conference call and live audio webcast on Thursday, May 7, 2026 at 8:30 a.m. [...] | ||
| 14:01 | Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event | |
| Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event. [...] | ||
| 14:00 | Fulcrum Therapeutics Aktie: Erwartungen übertroffen | |
| Pociredir-Daten überzeugen, der CFO verabschiedet sich — und die Aktie legt im vorbörslichen Handel zu. Fulcrum Therapeutics hat seinen Quartalsbericht für das erste Quartal 2026 vorgelegt und dabei mehr geliefert als erwartet. Besser als gedacht Der Nettoverlust fiel mit 18,9 Millionen Dollar zwar höher aus als im Vorjahreszeitraum (17,7 Millionen Dollar), der Verlust je Aktie lag mit 0,25 Dollar aber deutlich unter der Analystenerwartung von 0,30 Dollar. [...] | ||
| 14:00 | Cerence to Announce Fiscal Second Quarter Results on May 7, 2026 | |
| Cerence Inc. will announce its second quarter financial results for the quarter ended March 31, 2026, on Thursday, May 7, 2026.. [...] | ||
| 14:00 | Solésence, Inc. Announces Appointment of New Independent Director | |
| Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees. [...] | ||
| 14:00 | LifeMD to Report First Quarter 2026 Financial Results on May 6 | |
| NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2026, after the close of the U.S. financial markets on May 6, 2026, and will host a conference call beginning at 4:30 p.m. [...] | ||
| 14:00 | SONORO GOLD ANNOUNCES CLOSING OF OVERSUBSCRIBED $12.2M PRIVATE PLACEMENT | |
| VANCOUVER, Canada, April 27, 2026 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce that it has closed its previously announced oversubscribed, non-brokered private placement of 50,833,334 units (the “Units”) at $0.24 per unit, for gross proceeds of CAD $12,200,000. [...] | ||
| 14:00 | One Stop Systems to Report First Quarter 2026 Financial Results | |
| Conference Call to be Held Wednesday, May 6, 2026, at 10:00 a.m. ET Conference Call to be Held Wednesday, May 6, 2026, at 10:00 a.m. ET. [...] | ||
| 14:00 | DeFi Development Corp. to Announce First Quarter 2026 Financial Results | |
| BOCA RATON, FL, April 27, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it will publish its first quarter 2026 financial results and business outlook on its investor relations website at https://defidevcorp.com/investor?tab=Earnings on Wednesday, May 13, 2026, at approximately 4:15 p.m. [...] | ||
| 14:00 | BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 | |
| CARSON CITY, Nev., April 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that it will host a virtual key opinion leader (KOL) event on Thursday, May 7, 2026 at 2:00 PM ET featuring Suzanne de la Monte, MD, MPH (Brown University Warren Alpert Medical School, Providence VA Medical Center), who will join company management to discuss how bezisterim’s mechanism of action could potentially address the pathology and progression of neurodegenerative diseases, including Parkinson’s disease. [...] |
